Latest Developments in Wearable Devices for the Screening and Management of Atrial Fibrillation

doi:10.12114/j.issn.1007-9572.2022.0449

Chinese General Practice ›› 2023, Vol. 26 ›› Issue (01): 113-117.DOI: 10.12114/j.issn.1007-9572.2022.0449

Special Issue: 心房颤动最新文章合辑；心血管最新文章合辑

• Review • Previous Articles Next Articles

Latest Developments in Wearable Devices for the Screening and Management of Atrial Fibrillation

1.Center for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China
2.Jiangxi Clinical Cardiovascular Research Center, Nanchang 330006, China
3.Jiangxi Sub-center of National Clinical Research Center for Cardiovascular Diseases, Nanchang 330006, China
4.Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China

Received:2022-06-24 Revised:2022-10-20 Published:2023-01-05 Online:2022-11-03
Contact: CHENG Xiaoshu
About author:
YU C, ZHOU W, WANG T, et al. Latest developments in wearable devices for the screening and management of atrial fibrillation [J] . Chinese General Practice, 2023, 26 (1) : 113-117.

可穿戴设备支持心房颤动人群筛查与管理研究进展

1．330006　江西省南昌市，南昌大学第二附属医院心血管病防治中心
2．330006　江西省南昌市，江西省心血管疾病临床医学研究中心
3．330006　江西省南昌市，国家心血管疾病临床医学研究中心分中心
4．330006　江西省南昌市，南昌大学第二附属医院心血管内科

通讯作者: 程晓曙
作者简介:
余超，周伟，王涛，等.可穿戴设备支持心房颤动人群筛查与管理研究进展[J].中国全科医学，2023，26（1）：113-117.[www.chinagp.net] 作者贡献：余超负责文献检索、论文的构思与设计、文献及资料的整理，并撰写论文初稿；周伟负责文章选题、对初稿进行修订；王涛、祝玲娟参与文献检索及资料整理；鲍慧慧负责提出撰写思路；程晓曙负责最终版本修订，并对论文整体负责。
基金资助:
国家自然科学基金资助项目(82160070); 江西省科技创新基地建设项目(20221ZDG02010); 江西省卫健委科技计划项目(202130440，202210495，202310528); 江西省药品监督管理局计划项目(2022JS41); 南昌大学第二附属医院临床研究重点项目(2021efyA01); 南昌大学第二附属医院孵育项目(2021YNFY2024)

Abstract

Abstract:

Atrial fibrillation (AF) is one of the two major bastions that need to be tackled in cardiovascular disease field. The rates of AF screening and standardized management are low, which are mainly due to the limitation of "no onset symptoms of AF at the time of detection and no detection at the time of having onset symptoms of AF" in the traditional screening. Wearable devices are technologies that can facilitate early detection and scientific management of AF, whose applicability, sensitivity and specificity in the screening AF have been gradually verified. We reviewed the latest developments in wearable devices for AF screening and management, including epidemiological characteristics of AF, and current application, applicable limitations and prospect of wearable devices, providing a theoretical basis for the use of wearable devices in the screening and management of AF.

Key words: Atrial fibrillation, Wearable devices, Internet of things, Screening, Management

摘要：

心房颤动（简称房颤）是当代心血管领域亟须攻克的两大"堡垒"之一，而传统的房颤筛查存在"检测时未发病、发病时未检测"的局限，导致房颤管理存在检测率低、规范管理率低等不足。可穿戴设备为房颤早期发现和科学管理创造了技术条件，其在房颤筛查中的可行性、高灵敏度和特异度逐步得到验证。本文基于国内外相关文献，对可穿戴设备在房颤人群筛查与管理中的流行特征、应用现状、局限及前景等进行综述，以期为可穿戴设备用于房颤的筛查与管理提供理论依据。

关键词: 心房颤动, 可穿戴设备, 物联网, 筛查, 管理

YU Chao,ZHOU Wei,WANG Tao, et al. Latest Developments in Wearable Devices for the Screening and Management of Atrial Fibrillation[J]. Chinese General Practice, 2023, 26(01): 113-117. DOI: 10.12114/j.issn.1007-9572.2022.0449.
余超,周伟,王涛等. 可穿戴设备支持心房颤动人群筛查与管理研究进展[J]. 中国全科医学, 2023, 26(01): 113-117. DOI: 10.12114/j.issn.1007-9572.2022.0449.

Figures/Tables 2

References 38

[1]	CHUGH S S，ROTH G A，GILLUM R F，et al. Global burden of atrial fibrillation in developed and developing nations[J]. Glob Heart，2014，9（1）：113-119. DOI：10.1016/j.gheart.2014.01.004.
[2]	GBD 2017 HIV Collaborators. Global，regional，and national incidence，prevalence，and mortality of HIV，1980—2017，and forecasts to 2030，for 195 countries and territories：a systematic analysis for the Global Burden of Diseases，Injuries，and Risk Factors Study 2017[J]. Lancet HIV，2019，6（12）：831-859.
[3]	KIRCHHOF P，BENUSSI S，KOTECHA D，et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J，2016，37（38）：2893-2962. DOI：10.1093/ejcts/ezw313.
[4]	BENJAMIN E J，MUNTNER P，ALONSO A，et al. Heart Disease and Stroke Statistics-2019 update：a report from the American Heart Association[J]. Circulation，2019，139（10）：e56-528.
[5]	WANG Y J，LI Z X，GU H Q，et al. China Stroke Statistics 2019：a report from the National Center for Healthcare Quality Management in Neurological Diseases，China National Clinical Research Center for Neurological Diseases，the Chinese Stroke Association，National Center for Chronic and Non-communicable Disease Control and Prevention，Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol，2020，5（3）：211-239.
[6]	WANG X，FU Q，SONG F，et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke：results from a national stroke screening survey[J]. Int J Cardiol，2018，271：92-97. DOI：10.1016/j.ijcard.2018.05.131.
[7]	STAERK L，WANG B，PREIS S R，et al. Lifetime risk of atrial fibrillation according to optimal，borderline，or elevated levels of risk factors：cohort study based on longitudinal data from the Framingham Heart Study[J]. BMJ，2018，361：1-10.
[8]	YIIN G S，HOWARD D P，PAUL N L，et al. Age-specific incidence，outcome，cost，and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study[J]. Circulation，2014，130（15）：1236-1244.
[9]	VIRANI S S，ALONSO A，BENJAMIN E J，et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association[J]. Circulation，2020，141（9）：e139-596.
[10]	陈竺. 健康中国2020战略研究报告[M]. 北京：人民卫生出版社，2012.
[11]	KIRCHHOF P，BAX J，BLOMSTROM-LUNDQUIST C，et al. Early and comprehensive management of atrial fibrillation：executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference "research perspectives in AF"[J]. Eur Heart J，2009，30（24）：2969-2977. DOI：10.1093/eurheartj/ehp235.
[12]	GLADSTONE D J，SPRING M，DORIAN P，et al. Atrial fibrillation in patients with cryptogenic stroke[J]. N Engl J Med，2014，370（26）：2467-2477. DOI：10.1056/NEJMoa1311376.
[13]	CALKINS H，HINDRICKS G，CAPPATO R，et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Europace，2018，20（1）：1-160. DOI：10.1093/europace/eux274.
[14]	DU X，GUO L，XIA S，et al. Atrial fibrillation prevalence，awareness and management in a nationwide survey of adults in China[J]. Heart，2021，107（7）：535-541.
[15]	TURAKHIA M P，SHAFRIN J，BOGNAR K，et al. Estimated prevalence of undiagnosed atrial fibrillation in the United States[J]. PLoS One，2018，13（4）：1-11.
[16]	HINDRICKS G，POTPARA T，DAGRES N，et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery（EACTS）[J]. Eur Heart J，2021，42（5）：373-498. DOI：10.1093/eurheartj/ehaa612.
[17]	CHUA S K，CHEN L C，LIEN L M，et al. Comparison of arrhythmia detection by 24-hour holter and 14-day continuous electrocardiography patch monitoring[J]. Acta Cardiol Sin，2020，36（3）：251-259. DOI：10.1016/j.amjmed.2013.10.003.
[18]	ZAPRUTKO T，ZAPRUTKO J，BASZKO A，et al. Feasibility of atrial fibrillation screening with mobile health technologies at pharmacies[J]. J Cardiovasc Pharmacol Ther，2020，25（2）：142-151. DOI：10.1177/1074248419879089.
[19]	SIONTIS K C，GERSH B J，KILLIAN J M，et al. Typical，atypical，and asymptomatic presentations of new-onset atrial fibrillation in the community：characteristics and prognostic implications[J]. Heart Rhythm，2016，13（7）：1418-1424.
[20]	ATTIA Z I，NOSEWORTHY P A，LOPEZ-JIMENEZ F，et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm：a retrospective analysis of outcome prediction[J]. Lancet，2019，394（10201）：861-867. DOI：10.1016/S0140-6736(19)31721-0.
[21]	GUO Y，WANG H，ZHANG H，et al. Mobile photoplethysmographic technology to detect atrial fibrillation[J]. J Am Coll Cardiol，2019，74（19）：2365-2375.
[22]	TURAKHIA M P，DESAI M，HEDLIN H，et al. Rationale and design of a large-scale，APP-based study to identify cardiac arrhythmias using a smartwatch：the Apple Heart Study[J]. Am Heart J，2019，207：66-75. DOI：10.1016/j.ahj.2018.09.002.
[23]	HENRIKSEN A，HAUGEN MIKALSEN M，WOLDAREGAY A Z，et al. Using fitness trackers and smartwatches to measure physical activity in research：analysis of consumer wrist-worn wearables[J]. J Med Internet Res，2018，20（3）：110-118.
[24]	VARGHESE C，OYERE O，COWAN M，et al. World Health Organization[J]. Stroke，2016，47（8）：210. DOI：10.1161/STROKEAHA.116.014233.
[25]	DAS M，PANTER L，WYNN G J，et al. Primary care atrial fibrillation service：outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK[J]. BMJ Open，2015，5（12）：1-7.
[26]	PROIETTI M，ROMITI G F，OLSHANSKY B，et al. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC（Atrial Fibrillation Better Care） pathway[J]. Am J Med，2018，131（11）：1359-1366.
[27]	YOON M，YANG P S，JANG E，et al. Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC（Atrial Fibrillation Better Care） pathway for integrated care management: a nationwide cohort study[J]. Thromb Haemost，2019，119（10）：1695-1703.
[28]	PASTORI D，PIGNATELLI P，MENICHELLI D，et al. Integrated care management of patients with atrial fibrillation and risk of cardiovascular events：the ABC（Atrial Fibrillation Better Care） pathway in the ATHERO-AF study cohort[J]. Mayo Clin Proc，2019，94（7）：1261-1267. DOI：10.1016/j.mayocp.2018.10.022.
[29]	PASTORI D，FARCOMENI A，PIGNATELLI P，et al. ABC（Atrial Fibrillation Better Care） pathway and healthcare costs in atrial fibrillation：the ATHERO-AF study[J]. Am J Med，2019，132（7）：856-861. DOI：10.1016/j.amjmed.2019.01.003.
[30]	BAYOUMY K，GABER M，ELSHAFEEY A，et al. Smart wearable devices in cardiovascular care：where we are and how to move forward[J]. Nat Rev Cardiol，2021，18（8）：581-599.
[31]	GUO Y，LANE D A，WANG L，et al. Mobile health technology to improve care for patients with atrial fibrillation[J]. J Am Coll Cardiol，2020，75（13）：1523-1534.
[32]	HERMANS A，MONIKA G，LISA D，et al. A systematic review of mobile health opportunities for atrial fibrillation detection and management[J]. Eur J Prev Cardiol，2022，29（5）：205-208. DOI：10.1093/eurjpc/zwab158.
[33]	中国互联网络信息中心. 第50次《中国互联网络发展状况统计报告》[EB/OL].（2022-08-31）[2022-10-18].
[34]	DRAGOS V，LOPES R D，MCECILIA B，et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation（IMPACT-AF）：an international，cluster-randomised trial[J]. Lancet，2017，390（10104）：1737-1746. DOI：10.1016/S0140-6736(17)32165-7.
[35]	SHACHAM J，BIRATI E Y，MALOV N，et al. Telemedicine for diagnosing and managing paroxysmal atrial fibrillation in outpatients. The phone in the pocket[J]. Int J Cardiol，2012，157（1）：91-95. DOI：10.1016/j.ijcard.2010.12.014.
[36]	ZHOU M，FUKUOKA Y，GOLDBERG K，et al. Applying machine learning to predict future adherence to physical activity programs[J]. BMC Med Inform Decis Mak，2019，19（1）：169.
[37]	HASSELGREN A，KRALEVSKA K，GLIGOROSKI D，et al. Blockchain in healthcare and health sciences：a scoping review[J]. Int J Med Inform，2020，134：104040.
[38]	COHEN I G，MELLO M M. Big data，big tech，and protecting patient privacy[J]. JAMA，2019，322（12）：1141-1142. DOI：10.1001/jama.2019.11365.

房颤筛查工具/方法	灵敏度	特异度
触诊	87~97	70~81
自动血压监测仪	93~100	86~92
智能手机APP	91.5~98.5	91.4~100.0
ECG可穿戴设备	94~98	76~95
MCG可穿戴设备	67	99
PPG可穿戴设备	97~99	83~94

房颤筛查工具/方法	灵敏度	特异度
触诊	87~97	70~81
自动血压监测仪	93~100	86~92
智能手机APP	91.5~98.5	91.4~100.0
ECG可穿戴设备	94~98	76~95
MCG可穿戴设备	67	99
PPG可穿戴设备	97~99	83~94

内置传感器技术类型	设备内置传感器技术	测量指标	临床应用
运动类型	加速度计	步数、撞击力、速度、久坐时间、锻炼	房颤患者的风险评估^[1]，一、二级预防中的体育活动干预，心脏远程康复^[2]
	气压计	爬楼梯数（根据海拔高度的变化测定）
	GPS	运动距离、热量消耗等
生物识别	PPG	HR、HRR、HRV、血压、血氧饱和度、心搏出量、每搏量、基于脉搏的节律检测、睡眠及其阶段	房颤患者相关疾病的风险预测、房颤筛查与管理^[3] 、心脏远程康复、急性冠脉综合征诊断、电解质异常诊断（如高钾血症）、QTc间期延长诊断、药物滴定（如β-受体阻滞剂）
	ECG	单导联和多导联ECG，连续或按需ECG，间隔测量QTc间期、心律失常情况、电解质异常改变等
	MCG	腕带血压
其他类型	生化传感器^a	有创式血糖、电解质异常连续监测，无创式（结合衣服/鞋子）汗液、唾液电解质和水合状态监测	电解质异常检测（如高钾血症）、连续血糖监测、房颤管理^[4]
	生物力学传感器	心搏出量、每搏量、身体振动、体质量等	电解质异常检测（如高钾血症）、连续血糖监测、房颤管理^[4]

内置传感器技术类型	设备内置传感器技术	测量指标	临床应用
运动类型	加速度计	步数、撞击力、速度、久坐时间、锻炼	房颤患者的风险评估^[1]，一、二级预防中的体育活动干预，心脏远程康复^[2]
	气压计	爬楼梯数（根据海拔高度的变化测定）
	GPS	运动距离、热量消耗等
生物识别	PPG	HR、HRR、HRV、血压、血氧饱和度、心搏出量、每搏量、基于脉搏的节律检测、睡眠及其阶段	房颤患者相关疾病的风险预测、房颤筛查与管理^[3] 、心脏远程康复、急性冠脉综合征诊断、电解质异常诊断（如高钾血症）、QTc间期延长诊断、药物滴定（如β-受体阻滞剂）
	ECG	单导联和多导联ECG，连续或按需ECG，间隔测量QTc间期、心律失常情况、电解质异常改变等
	MCG	腕带血压
其他类型	生化传感器^a	有创式血糖、电解质异常连续监测，无创式（结合衣服/鞋子）汗液、唾液电解质和水合状态监测	电解质异常检测（如高钾血症）、连续血糖监测、房颤管理^[4]
	生物力学传感器	心搏出量、每搏量、身体振动、体质量等	电解质异常检测（如高钾血症）、连续血糖监测、房颤管理^[4]

Latest Developments in Wearable Devices for the Screening and Management of Atrial Fibrillation

可穿戴设备支持心房颤动人群筛查与管理研究进展

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 38

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949.
[2]	YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao. Research and Application of Digital Health Technologies in Multimorbidity Management [J]. Chinese General Practice, 2026, 29(21): 2933-2937.
[3]	CHEN Dian, LONG Huanyu, CHU Lanhe, JIANG Yixia, GUO Wanjin, NIU Yang, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2026 Report [J]. Chinese General Practice, 2026, 29(21): 2913-2932.
[4]	LI Chaohui, LIU Hui, WANG Kai. Identification of Factors Associated with Persistent Atrial Fibrillation and Development of a Classification Model [J]. Chinese General Practice, 2026, 29(20): 2846-2853.
[5]	CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807.
[6]	WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774.
[7]	CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758.
[8]	LI Wanyu, JIN Hua, YANG Sen, FU Qiangqiang, YU Dehua. Assessment and Optimization of Community Health Behaviors Guided by the Behaviour Change Wheel Theory [J]. Chinese General Practice, 2026, 29(19): 2688-2694.
[9]	CHEN Xinyi, HUANG Ziqian, CHEN Yufeng, HUANG Jun, WENG Fan, LAI Zhisheng, XUE Yumei, CAO Xi. Diagnostic Performance of a Hand-held Single-lead ECG Device in Detecting Atrial Fibrillation and Its Potential in Atrial Fibrillation Screening in Community [J]. Chinese General Practice, 2026, 29(19): 2717-2723.
[10]	ZHAO Xinran, WU Yibo, ZHANG Xuxi, CHEN Ping, SUN Xinying. The Current Situation and Influencing Factors of Smart Health Management Services and Devices Utilization among Chinese Adults: a Mixed Methods Study [J]. Chinese General Practice, 2026, 29(19): 2724-2734.
[11]	CHEN Qiulong, CHEN Jia, FANG Jing, DAI Wei, YANG Qing. Application Status and Research Progress of Observer-reported Outcome [J]. Chinese General Practice, 2026, 29(18): 2561-2570.
[12]	FAN Meixiang, YAN Yunyun, HUANG Yanyan. Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer [J]. Chinese General Practice, 2026, 29(18): 2450-2453.
[13]	General Practice Branch of Cross-straits Medicine Exchange Association, General Practice Branch of Zhejiang Medical Association, General Undifferentiated Disease Professional Committee of Zhejiang Society of Mathematical Medicine, Chinese Geriatrics Society. Expert Consensus on the Diagnosis, Treatment, and Management of Numbness (2025) [J]. Chinese General Practice, 2026, 29(18): 2433-2449.
[14]	SUN Xibin, LI Jiawei, GE Aoqi, YUAN Beibei. The Association between the Specialists Outreach and the Job Perception and Diabetes Management Competence of Primary Care Providers [J]. Chinese General Practice, 2026, 29(17): 2319-2325.
[15]	FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258.